Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Vaccine|March 11, 2014
Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individualsSharon E Frey, Patricia L Winokur, Heather Hill, et al.
F1000Research|July 24, 2018
RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reportingTravis L Jensen, Michael Frasketi, Kevin Conway, et al.
Vaccine|April 17, 2020
High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trialJack T Stapleton, Nancy Wagner, Rebecca Tuetken, et al.
The Journal of Infectious Diseases|August 15, 2012
Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routesShital M Patel, Robert L Atmar, Hana M El Sahly, et al.
The Journal of Infectious Diseases|August 13, 2008
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variantNega Ali Goji, Carrie Nolan, Heather Hill, et al.
Vaccine|February 7, 2022
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderlyGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
Vaccine|February 7, 2022
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery systemGeoffrey J Gorse, Stephen Grimes, Helen Buck, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Coccidioidomycosis acquired in Washington StateNicola Marsden-Haug, Marcia Goldoft, Cindy Ralston, et al.
The Journal of Infectious Diseases|September 24, 2008
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trialWendy A Keitel, James D Campbell, John J Treanor, et al.
Frontiers in Medicine|November 8, 2019
Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline EfficacyMark S Williams, Marianne R Baker, Tina Guina, et al.
Pageof 7